Pasithea Therapeutics (KTTA) Net Income (2021 - 2024)
Historic Net Income for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to -$3.2 million.
- Pasithea Therapeutics' Net Income fell 1870829.24% to -$3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$13.9 million, marking a year-over-year decrease of 296329.1%. This contributed to the annual value of -$13.9 million for FY2024, which is 296329.1% down from last year.
- Pasithea Therapeutics' Net Income amounted to -$3.2 million in Q4 2024, which was down 1870829.24% from -$3.0 million recorded in Q3 2024.
- Pasithea Therapeutics' Net Income's 5-year high stood at $630143.0 during Q4 2021, with a 5-year trough of -$3.9 million in Q2 2024.
- Over the past 4 years, Pasithea Therapeutics' median Net Income value was -$549609.0 (recorded in 2021), while the average stood at -$1.3 million.
- Its Net Income has fluctuated over the past 5 years, first skyrocketed by 9841.25% in 2023, then tumbled by 1870829.24% in 2024.
- Pasithea Therapeutics' Net Income (Quarter) stood at $630143.0 in 2021, then tumbled by 268.9% to -$1.1 million in 2022, then surged by 98.41% to -$16895.0 in 2023, then plummeted by 18708.29% to -$3.2 million in 2024.
- Its Net Income was -$3.2 million in Q4 2024, compared to -$3.0 million in Q3 2024 and -$3.9 million in Q2 2024.